Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

EPA’s Proposed RFS Rules Continue to Undercut Advanced Biofuels, BIO Says

EPA has again proposed rules for the Renewable Fuel Standard that will continue to chill investment in the advanced biofuel sector and increase climate changing emissions.

BIO 2015 to Host an Evening Keynote with Wynton Marsalis

Leading Jazz Musician to share his insights about the correlation between artists and entrepreneurs at the 2015 BIO International Convention

North Carolina Governor McCrory Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

BIO & NCBIO commend Governor Pat McCrory for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Applauds Energy and Commerce Committee for Approving 21st Century Cures Act

Biotechnology Industry Organization praises the Energy and Commerce Committee for approving the 21st Century Cures Act

BIO'S Letter to House Appropriations Agriculture Committee re Section 9003 of the Agricultural Act of 2014

On behalf of the biotechnology industry we are writing to encourage your support of full funding of Section 9003 of the Agricultural Act of 2014 (Public Law 113-79), the Biorefinery, Renewable Chemical, and Biobased Manufacturing Assistance Program, as you develop the Fiscal Year 2016 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act.

BIO Applauds the U.S. House of Representatives for Passage of the American Research and Competitiveness Act

By making this tax credit permanent, companies conducting their development programs will be able to estimate their tax liability and will not be burdened by the constant uncertainty regarding whether or not the R&D Tax Credit will be extended.

BIO Comments on FDA Draft Guidance: Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application

BIO applauds the issuance by the Food and Drug Administration (FDA) of the Draft Guidance entitled, “Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application.” (Draft Guidance)1 The policies and recommendations set forth in the Draft Guidance, when finalized, represent critical steps forward in the effort to protect patients from biological products prepared under conditions that could result in their contamination or a lack of effectiveness.

EPA Should Reissue the 2014 RFS Proposal Consistent with the Statute, BIO Says

It is imperative that the Environmental Protection Agency gets the administration of the annual Renewable Fuel Standard (RFS) renewable volume obligations (RVOs) back on track, BIO wrote today.

Solazyme CEO Jonathan S. Wolfson to Receive the 2015 BIO George Washington Carver Award

The Biotechnology Industry Organization (BIO) named Solazyme CEO and co-founder Jonathan S. Wolfson as the recipient of its 2015 George Washington Carver Award for innovation in industrial biotechnology. Wolfson will receive the award and give a brief talk at the upcoming BIO World Congress on Industrial Biotechnology in July in Montreal, Canada. 

BIO Submits Comments on Electronic Distribution of Prescribing Information NPRM

The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit comments on the Proposed Rule entitled “Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products.”